+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Evaluation of three APTT reagents in a routine laboratory: toward a compromise

Evaluation of three APTT reagents in a routine laboratory: toward a compromise

Clinical Laboratory 59(7-8): 921-924

Our current activated partial thromboplastin time (APTT) reagent (PTT-A) is often prolonged for unexplained reasons. We decided to compare this reagent with an alternative reagent (Cephascreen) and with our second line APTT (Actin FS) in terms of cut-off values, sensitivity to in-vitro coagulation factor deficiencies, sensitivity to lupus anticoagulant (LA), and in vivo sensitivity to unfractionated heparin (UFH). Actin FS, PTT-A, and Cephascreen were prolonged for FVIII level at 60%, 40%, and 40% respectively, FIX at 50%, 25%, and 35%, and FXI at 60%, 20%, and 50%. PTT-A showed the same sensitivity and specificity as Cephascreen to LA. Actin FS and PTT-A appeared less suitable to monitor UFH regarding the CLSI criteria. Cephascreen fulfilled the CLSI performance criteria, with a good compromise in terms of sensitivity to factor deficiency and with a substantial reduction of complementary analysis in our routine practice.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 053088794

Download citation: RISBibTeXText

PMID: 24133925

Related references

Variation of APTT EQA Results Obtained with Various Combinations of Coagulation Instruments and APTT Reagents. Blood 100(11): Abstract No 3863, 2002

Effect of clot-detection methods and reagents on activated partial thromboplastin time (APTT). Implications in heparin monitoring by APTT. American Journal of Clinical Pathology 94(3): 297-306, 1990

Comparative evaluation of 17 commercial APTT reagents. Australian Journal of Medical Science 15(4): 133-140, 1994

Isolated factor V deficiency in a patient with elevated PT and aPTT during routine pre-operative laboratory screening. Stem Cell Investigation 1: 4, 2014

Monitoring unfractionated heparin with APTT: a French collaborative study comparing sensitivity to heparin of 15 APTT reagents. Thrombosis Research 129(5): 666-667, 2012

Evaluation of activated partial thromboplastin time (aPTT) reagents for application in biomedical diagnostic device development. International Journal of Laboratory Hematology 33(3): 272-280, 2011

Evaluation of the activated partial thromboplastin time (APTT) sensitivity to heparin using five commercial reagents: implications for therapeutic monitoring. Clinical Chemistry and Laboratory Medicine 36(12): 975-980, 1999

Lupus anticoagulant evaluation of sensitivity of various laboratory tests at different levels of aptt. American Journal of Clinical Pathology 90(4): 508, 1988

Evaluation of coagulometric assays in the assessment of protein C anticoagulant activity; variable sensitivity of commercial APTT reagents to the cofactor effect of protein S. Thrombosis and Haemostasis 62(3): 861-867, 1989

Frontiers in the serologic laboratory: alternative sources of routine reagents. Progress in Clinical and Biological Research 43: 291-303, 1980

Use of INR calibrator plasmas in the routine coagulation laboratory: a study of two thrombolastin reagents. Thrombosis Research 130(3): E158-E162, 2012

A comparison of two APTT reagents which use silica activators. Clinical and Laboratory Haematology 11(3): 221-232, 1989

Variability in heparin sensitivity of APTT reagents. American Journal of Clinical Pathology 86(2): 199-204, 1986

APTT reagents for different coagulation tests: one size does not fit all. American Journal of Clinical Pathology 138(5): 757; Author Reply 757-8, 2012

Effects of two different doses of hirudin on APTT, determined with eight different reagents. Thrombosis and Haemostasis 73(2): 219-222, 1995